Related references
Note: Only part of the references are listed.Human airway mast cells proliferate and acquire distinct inflammation-driven phenotypes during type 2 inflammation
Daniel F. Dwyer et al.
SCIENCE IMMUNOLOGY (2021)
Combined histochemical approach in assessing tryptase expression in the mast cell population
D. A. Atiakshin et al.
ACTA HISTOCHEMICA (2021)
Identification of CTLA-4-Positive Cells in the Human Tonsil
Markus Tiemann et al.
CELLS (2021)
Role of Mast Cells in Shaping the Tumor Microenvironment
Daniel Elieh Ali Komi et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2020)
The Roles of CD38 and CD157 in the Solid Tumor Microenvironment and Cancer Immunotherapy
Yu Jun Wo et al.
CELLS (2020)
Is There a Future for Anti-CD38 Antibody Therapy in Systemic Autoimmune Diseases?
Devis Benfaremo et al.
CELLS (2020)
Roles of CD38 in the Immune Response to Infection
Estibaliz Glaria et al.
CELLS (2020)
The Good, the Bad and the Unknown of CD38 in the Metabolic Microenvironment and Immune Cell Functionality of Solid Tumors
Jessica M. Konen et al.
CELLS (2020)
NK cells and CD38: Implication for (Immuno)Therapy in Plasma Cell Dyscrasias
Renato Zambello et al.
CELLS (2020)
Mast Cell β-Tryptase Is Enzymatically Stabilized by DNA
Sultan Alanazi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Plasma cells, plasmablasts, and AID+/CD30+B lymphoblasts inside and outside germinal centres: details of the basal light zone and the outer zone in human palatine tonsils
Birte S. Steiniger et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2020)
CD38, a Receptor with Multifunctional Activities: From Modulatory Functions on Regulatory Cell Subsets and Extracellular Vesicles, to a Target for Therapeutic Strategies
Fabio Morandi et al.
CELLS (2019)
Therapeutic Opportunities with Pharmacological Inhibition of CD38 with Isatuximab
Thomas G. Martin et al.
CELLS (2019)
Multiple immunolabeling with antibodies from the same host species in combination with tyramide signal amplification
Igor Buchwalow et al.
ACTA HISTOCHEMICA (2018)
Hydroxychloroquine as a novel therapeutic approach in mast cell activation diseases
Eric Espinosa et al.
CLINICAL IMMUNOLOGY (2018)
CD38 Antibodies in Multiple Myeloma: Mechanisms of Action and Modes of Resistance
Niels W. C. J. van de Donk et al.
FRONTIERS IN IMMUNOLOGY (2018)
Adult Connective Tissue-Resident Mast Cells Originate from Late Erythro-Myeloid Progenitors
Zhiqing Li et al.
IMMUNITY (2018)
Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts
Peter Valent et al.
BLOOD (2017)
Tryptase-catalyzed core histone truncation: A novel epigenetic regulatory mechanism in mast cells
Fabio R. Melo et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Monocytes and Granulocytes Reduce CD38 Expression Levels on Myeloma Cells in Patients Treated with Daratumumab
Jakub Krejcik et al.
CLINICAL CANCER RESEARCH (2017)
Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma
Jakub Krejcik et al.
BLOOD (2016)
Plasma cells as an innovative target in autoimmune disease with renal manifestations
Falk Hiepe et al.
NATURE REVIEWS NEPHROLOGY (2016)
CD38 and CD157: A long journey from activation markers to multifunctional molecules
Valeria Quarona et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2013)
Mast cell synapses and exosomes: membrane contacts for information exchange
Amanda Carroll-Portillo et al.
FRONTIERS IN IMMUNOLOGY (2012)
Non-specific binding of antibodies in immunohistochemistry: fallacies and facts
Igor Buchwalow et al.
SCIENTIFIC REPORTS (2011)
Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology
Fabio Malavasi et al.
PHYSIOLOGICAL REVIEWS (2008)
CD38 signaling in T cells is initiated within a subset of membrane rafts containing Lck and the CD3-ζ subunit of the T cell antigen receptor
P Muñoz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Cytokines regulate development of human mast cells from hematopoietic progenitors
T Nakahata et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2002)
Human CD38: a (r)evolutionary story of enzymes and receptors
S Deaglio et al.
LEUKEMIA RESEARCH (2001)
Share Paper
